SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2022 Results Conference Call August 9, 2022 8:30 AM ET
Company Participants
Jennifer Pottage – Head, IR
Dr. Jurgi Camblong – Co-Founder and CEO
Ross Muken – CFO
Conference Call Participants
Julia Qin – JP Morgan
Vidyun Bais – BTIG
Kyle Boucher – Cowen
Operator
Good day, and welcome to the SOPHiA GENETICS Second Fiscal Quarter 2022 Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Jennifer Pottage, Head of Investor Relations. Please go ahead.
Jennifer Pottage
Welcome to SOPHiA GENETICS’ Second Fiscal 2022 Earnings Conference Call. My name is Jennifer Pottage, and I’m the Head of Investor Relations at SOPHiA GENETICS. Joining me today are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; and Ross Muken, our Chief Financial Officer.
Before we get started, I would like to remind you that management will make statements during this call that are forward looking within the scope of U.S. federal securities laws. These statements are based on management’s current views and assumptions which are subject to material risks and uncertainties that could cause actual results or events to differ materially from those projected. Additional information regarding these risks and uncertainties are included in the section entitled cautionary statement regarding forward-looking statements and Exhibit 99.2 of the report on Form 6-K filed today with the SEC.
Except as required by law, SOPHiA GENETICS disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of its broadcast, August 9, 2022.
Please note, the replay of this call as well as the earnings release and associated slides will be available on our website in the Investors section.
And now I’ll